Charles River price target lowered to $166 from $205 at Barclays

Barclays analyst Luke Sergott lowered the firm’s price target on Charles River (CRL) to $166 from $205 and keeps an Equal Weight rating on the shares. Sentiment remains very bearish on the life science tools group from a focus on National Institutes of Health funding cuts impacting demand, the analyst tells investors in a research note.